Ad
Search
Generic filters
Filter by content type
Taxonomy terms

TELA – TELA Bio Inc

🔒

Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.

Get started from just $1/month

Ad

Recommendation Rating

1.6

1

2

3

4

5

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 18.8

Low: 15

High: 22

Total Analysts: 5

Company Profile

TELA Bio Inc. is a medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. The Company’s first portfolio of solutions offers four configurations of the OviTex Reinforced Tissue Matrix (OviTex) designed for hernia repair and abdominal wall reconstruction by combining the benefits of biologic matrices and polymer materials. The Company’s OviTex products include OviTex 1S, OviTex 2S, and OviTex LPR. The OviTex products are sterile reinforced tissue matrices derived from ovine rumen with either polypropylene or polyglycolic acid (PGA). The Company’s second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Ad

Responses